Found 16 matching trials
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma PHASE2 RATIONALE: Monoclonal antibodies such as yttrium Y 90 ibritumomab tiuxetan ...
Show More Location
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Learn More & Join Trial
Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE1 RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Show More Location
Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
Learn More & Join Trial
Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular Non Hodgkin's Lymphoma (NHL) PHASE3 This study will treat follicular lymphoma patients who have not received pr...
Show More Location
Integrated Community Oncology Network
Learn More & Join Trial
A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen PHASE3 This is a multi-center, randomized, study to compare Iodine I 131 Tositumom...
Show More Location
GSK Clinical Trials Call Center
Learn More & Join Trial
Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma PHASE1 The study evaluates the additional use of radioimmunotherapy with a 90-Yttr...
Show More Location
Medical Center Charite Benjamin Franklin
Learn More & Join Trial
Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta) PHASE3 The purpose of this study is to evaluate the effect of consolidation treatm...
Show More Location
21st Century Oncology
Learn More & Join Trial
Ibritumomab Tiuxetan (Zevalin)+ Rituximab Maintenance PHASE2 Subjects will receive the Ibritumomab Tiuxetan (Zevalin) therapeutic regime...
Show More Location
University Of Wisconsin
Learn More & Join Trial
High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma PHASE2 This phase II trial studies the side effects and how well high-dose yttrium...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma PHASE3 The purpose of this study is to provide treatment for patients who have rel...
Show More Learn More & Join Trial